Argent Biopharma Ltd (RGT) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.379x

Based on the latest financial reports, Argent Biopharma Ltd (RGT) has a cash flow conversion efficiency ratio of 0.379x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-3.27 Million ≈ $-2.31 Million USD) by net assets (AU$-8.63 Million ≈ $-6.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See RGT equity financing ratio to measure how much of total assets are equity-financed.

Argent Biopharma Ltd - Cash Flow Conversion Efficiency Trend (2006–2023)

This chart illustrates how Argent Biopharma Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Argent Biopharma Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Argent Biopharma Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Argent Biopharma Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Videndum Plc LSE:VID	-0.201x
Lavoro Limited Class A Ordinary Shares NASDAQ:LVRO	-0.676x
Australian Silica Quartz Group Ltd AU:ASQ	-0.107x
Champion Bear Resources Ltd. V:CBA	-0.023x
Qiiwi Games AB (publ) ST:QIIWI	-0.078x
Clean & Carbon Energy S.A. WAR:CCE	-0.044x
HiteJinro Holdings Co Ltd KO:000145	-0.020x
Enlivex Therapeutics Ltd TA:ENLV	-0.131x

Annual Cash Flow Conversion Efficiency for Argent Biopharma Ltd (2006–2023)

The table below shows the annual cash flow conversion efficiency of Argent Biopharma Ltd from 2006 to 2023. For the full company profile with market capitalisation and key ratios, see market cap of Argent Biopharma Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2023-06-30	AU$-8.03 Million ≈ $-5.68 Million	AU$-11.99 Million ≈ $-8.48 Million	1.492x	+163.57%
2022-06-30	AU$5.18 Million ≈ $3.67 Million	AU$-12.16 Million ≈ $-8.60 Million	-2.347x	-170.67%
2021-06-30	AU$13.83 Million ≈ $9.78 Million	AU$-11.99 Million ≈ $-8.48 Million	-0.867x	+73.05%
2020-06-30	AU$3.09 Million ≈ $2.19 Million	AU$-9.96 Million ≈ $-7.05 Million	-3.218x	-446.82%
2019-06-30	AU$10.80 Million ≈ $7.64 Million	AU$-6.35 Million ≈ $-4.50 Million	-0.588x	-26.86%
2018-06-30	AU$12.69 Million ≈ $8.98 Million	AU$-5.89 Million ≈ $-4.17 Million	-0.464x	-57.30%
2017-06-30	AU$15.79 Million ≈ $11.17 Million	AU$-4.66 Million ≈ $-3.29 Million	-0.295x	-7.40%
2016-06-30	AU$11.73 Million ≈ $8.30 Million	AU$-3.22 Million ≈ $-2.28 Million	-0.275x	+14.35%
2015-06-30	AU$1.93 Million ≈ $1.36 Million	AU$-617.71K ≈ $-437.07K	-0.321x	-208.50%
2014-06-30	AU$4.55 Million ≈ $3.22 Million	AU$-472.74K ≈ $-334.49K	-0.104x	-54.01%
2013-06-30	AU$7.94 Million ≈ $5.62 Million	AU$-536.08K ≈ $-379.31K	-0.067x	+86.00%
2012-06-30	AU$787.42K ≈ $557.15K	AU$-379.45K ≈ $-268.48K	-0.482x	-17.80%
2011-06-30	AU$828.30K ≈ $586.08K	AU$-338.82K ≈ $-239.74K	-0.409x	-223.14%
2010-06-30	AU$-3.14 Million ≈ $-2.22 Million	AU$-1.04 Million ≈ $-737.66K	0.332x	-99.30%
2009-06-30	AU$-8.79K ≈ $-6.22K	AU$-416.04K ≈ $-294.38K	47.331x	+20017.04%
2008-06-30	AU$1.94 Million ≈ $1.37 Million	AU$-460.26K ≈ $-325.67K	-0.238x	+44.28%
2007-06-30	AU$3.81 Million ≈ $2.70 Million	AU$-1.63 Million ≈ $-1.15 Million	-0.426x	-2973.25%
2006-06-30	AU$2.76 Million ≈ $1.95 Million	AU$41.00K ≈ $29.01K	0.015x	--

About Argent Biopharma Ltd

AU:RGT Australia Drug Manufacturers - Specialty & Generic

Market Cap

$2.99 Million

AU$4.22 Million AUD

Market Cap Rank

#29476 Global

#1670 in Australia

Share Price

AU$0.04

Change (1 day)

+0.00%

52-Week Range

AU$0.03 - AU$0.15

All Time High

AU$125.00